Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Durata Therapeutics,
Inc. (“Durata” or the “Company”) (Nasdaq: DRTX) relating to the proposed
acquisition by Actavis plc.
for SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Durata Therapeutics, Inc. in Connection with the Sale of the Company investment picks